Home » Topics » Regulatory » Patents

Patents
RSS

New tachykinin antagonists from Schering-Plough

Jan. 8, 1998

Selective dopamine D3 ligands revealed by Neurogen

Jan. 8, 1998

New AIDS treatment candidates disclosed by Vertex

Jan. 8, 1998

New NMDA/AMPA antagonists synthesized at Merck & Co.

Jan. 8, 1998

New vitamin D conjugates disclosed by Clarion

Jan. 8, 1998

PLA2 inhibitors described by Santen

Jan. 8, 1998

New antifungal antibiotic TKR-842 from Takara Shuzo

Jan. 8, 1998

New carbapenems in development at Takeda

Jan. 8, 1998

COX-2 inhibitors under study at Abbott

Jan. 8, 1998

Protein farnesyltransferase inhibitors disclosed by Schering-Plough

Jan. 8, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...